Crasta Manuela, Clode Alison B, McMullen Richard J, Pate Diana O, Gilger Brian C
Clinica Veterinaria Visionvet, Bologna 40017, Italy.
Vet Ophthalmol. 2010 Jan;13(1):14-9. doi: 10.1111/j.1463-5224.2009.00748.x.
To compare the effect of topical latanoprost, intracameral carbachol, or no adjunctive medical therapy on the development of acute postoperative hypertension (POH) and inflammation after routine phacoemulsification and aspiration (PA) of cataracts in dogs.
Retrospective study.
Dogs received either one drop of topical 0.005% latanoprost (21 dogs, 39 eyes), an intracameral injection of 0.3 mL of 0.01% carbachol (15 dogs, 30 eyes), or no adjunctive therapy (46 dogs, 90 eyes) immediately following PA of cataract(s). Intraocular pressure (IOP) was measured in all dogs 2 and 4 h after surgery. IOP was measured and aqueous flare assessed at 8 am the day after surgery.
Carbachol-treated dogs had significantly higher mean IOP (33.2 +/- SD 20.8 mmHg) 2 h after surgery than dogs receiving no adjunctive therapy (22.0 +/- SD 14.1 mmHg) (P = 0.049). There were no significant differences in IOP among groups at any other time point. There were no significant differences in number of POH episodes between dogs treated with carbachol (47%), latanoprost (29%), or dogs that received no adjunctive therapy (33%). There were no significant differences in mean aqueous flare grade between eyes treated with latanoprost (1.7 +/- SD 0.4) or carbachol (1.4 +/- SD 0.6), and eyes that received no adjunctive therapy (1.7 +/- SD 0.4).
Topical 0.005% latanoprost or intracameral injection of 0.3 mL of 0.01% carbachol after PA in dogs did not reduce POH or increase intraocular inflammation compared to dogs not receiving adjunctive therapy after PA of cataracts.
比较局部应用拉坦前列素、前房内注射卡巴胆碱或不进行辅助药物治疗对犬白内障常规超声乳化吸除术(PA)后急性术后高血压(POH)和炎症发展的影响。
回顾性研究。
犬在白内障PA术后立即接受以下治疗之一:一滴局部用0.005%拉坦前列素(21只犬,39只眼)、前房内注射0.3 mL 0.01%卡巴胆碱(15只犬,30只眼)或不进行辅助治疗(46只犬,90只眼)。所有犬在术后2小时和4小时测量眼压(IOP)。在术后第二天上午8点测量IOP并评估房水闪光。
卡巴胆碱治疗的犬术后2小时平均IOP(33.2±标准差20.8 mmHg)显著高于未接受辅助治疗的犬(22.0±标准差14.1 mmHg)(P = 0.049)。在其他任何时间点,各组之间的IOP均无显著差异。接受卡巴胆碱治疗的犬(47%)、拉坦前列素治疗的犬(29%)或未接受辅助治疗的犬(33%)之间POH发作次数无显著差异。接受拉坦前列素治疗的眼(1.7±标准差0.4)或卡巴胆碱治疗的眼(1.4±标准差0.6)与未接受辅助治疗的眼(1.7±标准差0.4)之间平均房水闪光分级无显著差异。
与白内障PA术后未接受辅助治疗的犬相比,犬PA术后局部应用0.005%拉坦前列素或前房内注射0.3 mL 0.01%卡巴胆碱并不能降低POH或增加眼内炎症。